Rybelsus®
Les comprimés de Rybelsus (semaglutide) sont un médicament d'ordonnance utilisé chez les adultes atteints de diabète sucré de type 2 pour diminuer le taux de sucre dans le sang. Rybelsus peut être prescrit lorsque d'autres médicaments contre le diabète ont été essayés sans succès et doivent être utilisés avec un régime alimentaire et de l'exercice. Les comprimés de Rybelsus agissent pour abaisser les niveaux de sucre dans le sang (glucose) en augmentant la quantité d'insuline li
Active Ingredient: semaglutide
Availability: In Stock (85 packages)
Rybelsus®, 3mg
| Paquet | Per Pack | Achetez | |
|---|---|---|---|
| 10 tablet x 3mg | $20.00 | $199.95 | |
20 tablet x 3mg
Free airmail shipping |
$18.00 |
|
|
30 tablet x 3mg
Free airmail shipping |
$17.00 |
|
|
60 tablet x 3mg
Free airmail shipping |
$16.00 |
|
|
90 tablet x 3mg
Free airmail shipping |
$15.00 |
|
Rybelsus®, 7mg
| Paquet | Per Pack | Achetez | |
|---|---|---|---|
| 10 tablet x 7mg | $20.00 | $199.95 | |
20 tablet x 7mg
Free airmail shipping |
$19.50 |
|
|
30 tablet x 7mg
Free airmail shipping |
$19.00 |
|
|
60 tablet x 7mg
Free airmail shipping |
$18.50 |
|
Rybelsus®, 14mg
| Paquet | Per Pack | Achetez | |
|---|---|---|---|
10 tablet x 14mg
Free airmail shipping |
$24.00 | $239.95 | |
20 tablet x 14mg
Free airmail shipping |
$23.00 |
|
|
30 tablet x 14mg
Free airmail shipping |
$22.50 |
|
|
60 tablet x 14mg
Free airmail shipping |
$22.00 |
|
Description du produit
Emballage
Rybelsus® (Semaglutide)
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.
Packaging info
This is how your parcel will look like, the images are photographs of real shipments.
It has the size of a normal protected envelope and it does not disclose its contents.
